SCHEMBL12435941

SCHEMBL12435941

CCNc1cc(C(=O)Nc2ccc(OC)c(OC)c2)ccc1CO

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
ALDH1A1 P00352 4/20 0.56
TP53 P04637 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
LMNA P02545 1/20 0.53
HPGD P15428 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
PKM P14618 2/20 0.52
NQO2 P16083 1/20 0.52
CASP3 P42574 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
ROCK2 O75116 1/20 0.51
POLB P06746 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
NAMPT P43490 2/20 0.49
MAPT P10636 3/20 0.49
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12435942 0.86 NPC1 (0.57) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL12436024 0.84 ALDH1A1 (0.60) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL17507482 0.78 NPC1 (0.61) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL12435980 0.78 NAMPT (0.50) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL12435909 0.76 ATM (0.52) ALDH1A1TP53SMN1; SMN2LMNAPKM
SCHEMBL12435962 0.76 MAPT (0.49) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL17512395 0.76 MAPT (0.61) NPC1RAB9AALDH1A1TP53SMN1; SMN2
SCHEMBL12435916 0.75 ATM (0.54) ALDH1A1TP53SMN1; SMN2LMNAPOLB
SCHEMBL12436020 0.75 TDP1 (0.51) ALDH1A1SMN1; SMN2LMNAHPGDPKM
SCHEMBL12436021 0.75 STAT3 (0.48) NPC1RAB9AALDH1A1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Academy of Medical Science (CN) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use CUL3, APOBEC3G, BRPF3 NPC1 3314/4885RAB9A 1374/4885ALDH1A1 2851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.